Carol A. Kruse

2.3k citations
62 papers · 1.7k indexed · h-index 24
  • Genetics top 2%
    • Glioma Diagnosis and Treatment 16
    • Virus-based gene therapy research 10
  • Immunology top 5%
    • Immunotherapy and Immune Responses 22
    • Immune Cell Function and Interaction 9
  • Oncology top 5%
    • CAR-T cell therapy research 12
  • Neurology top 5%
    • Neuroinflammation and Neurodegeneration Mechanisms 8
  • Neurology top 10%
    • Neuroinflammation and Neurodegeneration Mechanisms 8
    • RNA Interference and Gene Delivery 10
    • Cancer Research and Treatments 6

Carol A. Kruse

61 papers receiving 1.7k citations

Peers

Carol A. Kruse
Comparison fields: 5 of 94
  • Genetics 369
  • Immunology 697
  • Oncology 603
  • Neurology 141
  • Neurology 175
Replace Moneeb Ehtesham with:
Moneeb Ehtesham United States
J. Kuratsu Japan
Nahid Tayebi United States
Lawrence C. Kenyon United States
Wendy Yang United States
Denise M. Gibo United States
John Choi United States
Aytaç Akbaşak Türkiye
Katharine A. Whartenby United States
Michal J. Besser Israel
Carol A. Kruse relative to Moneeb Ehtesham United States Moneeb Ehtesham's profile →
Citations per field
00.5×2.5×
Moneeb Ehtesham · 1×
Citations per year

Countries citing papers authored by Carol A. Kruse

Since Specialization
Citations

This map shows the geographic impact of Carol A. Kruse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol A. Kruse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol A. Kruse more than expected).

Fields of papers citing papers by Carol A. Kruse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol A. Kruse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol A. Kruse. The network helps show where Carol A. Kruse may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carol A. Kruse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carol A. Kruse Line = papers co-authored together Carol A. Kruse links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201536
2 201527
3 2014282
4 20135
5 20132
6 201220
7 200864
8 200418
9 200418
10 200330
11 20039
12 200213
13 200124
14 200118
15 19989
16 199711
17 199512
18 199428
19 199324
20 199218

About Carol A. Kruse

Carol A. Kruse is a scholar working on Genetics, Immunology and Neurology, having authored 62 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (22 papers), Glioma Diagnosis and Treatment (16 papers), CAR-T cell therapy research (12 papers), Virus-based gene therapy research (10 papers), RNA Interference and Gene Delivery (10 papers), Immune Cell Function and Interaction (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers) and Cancer Research and Treatments (6 papers). The work is most often cited by research in Genetics (369 citations), Immunology (697 citations) and Oncology (603 citations). Carol A. Kruse has collaborated with scholars based in United States, Italy and Austria. Frequent co-authors include German G. Gomez, Bette K. Kleinschmidt‐DeMasters, Dawn H. Mitchell, Gary W. Mathern, Kevin O. Lillehei, Carlos A. Pardo, J. Helen Cross, Frances E. Jensen, Sophia Varadkar and Angela Vincent. Their work appears in journals such as The Journal of Immunology, JNCI Journal of the National Cancer Institute and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026